Yew Bio-Pharm Group, Inc. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

$27.3M

Net Income/Loss (FY2020)

$1.5M

Total Assets (FY2020)

$58.4M

Total Equity (FY2020)

$45.5M

Cash Flows from Operating Activities (FY2020)

$17.3M

Source: Yew Bio-Pharm Group, Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.